Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis

被引：0
|
作者：
Sridhar Murahari
Aimee L. Jalkanen
Samuel K. Kulp
Ching-Shih Chen
Jaime F. Modiano
Cheryl A. London
William C. Kisseberth
机构：
[1] The Ohio State University,Department of Veterinary Clinical Sciences, College of Veterinary Medicine
[2] The Ohio State University,Department of Veterinary Biosciences, College of Veterinary Medicine
[3] The Ohio State University,Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy
[4] University of Minnesota,Department of Veterinary Clinical Sciences, College of Veterinary Medicine
[5] University of Minnesota,Masonic Cancer Center
[6] Colorado State University,Current address: Department of Microbiology, Immunology and Pathology
来源：
BMC Cancer | / 17卷
关键词：
Apoptosis; AR-42; Dog; Histone deacetylase inhibitor; Osteosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways
    Chen, Yi-Jin
    Wan, Wen-Hung
    Wu, Wan-Yu
    Hsu, Chia-Chi
    Wei, Ling-Rung
    Wang, Sheng-Fan
    Hsu, Ya-Wen
    Liaw, Chih-Chuang
    Tsai, Wan-Chi
    PLOS ONE, 2017, 12 (08):
  • [22] AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit
    Lin, Tzu-Yin
    Fenger, Joelle
    Murahari, Sridhar
    Bear, Misty D.
    Kulp, Samuel K.
    Wang, Dasheng
    Chen, Ching-Shih
    Kisseberth, William C.
    London, Cheryl A.
    BLOOD, 2010, 115 (21) : 4217 - 4225
  • [23] Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
    Tseng, Yu-Chou
    Kulp, Samuel K.
    Lai, I-Lu
    Hsu, En-Chi
    He, Wei A.
    Frankhouser, David E.
    Yan, Pearlly S.
    Mo, Xiaokui
    Bloomston, Mark
    Lesinski, Gregory B.
    Marcucci, Guido
    Guttridge, Denis C.
    Bekaii-Saab, Tanios
    Chen, Ching-Shih
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (12):
  • [24] The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells
    Zhang, Shuhong
    Suvannasankha, Attaya
    Crean, Colin D.
    White, Valerie L.
    Chen, Ching-Shih
    Farag, Sherif S.
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (01) : 204 - 213
  • [25] Polyamines regulate sensitivity to HDAC inhibitor-induced apoptosis
    Saunders, Laura R.
    Verdin, Eric
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia
    Guzman, Monica L.
    Yang, Neng
    Sharma, Krishan K.
    Balys, Marlene
    Corbett, Cheryl A.
    Jordan, Craig T.
    Becker, Michael W.
    Steidl, Ulrich
    Abdel-Wahab, Omar
    Levine, Ross L.
    Marcucci, Guido
    Roboz, Gail J.
    Hassane, Duane C.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (08) : 1979 - 1990
  • [27] Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP
    K Watanabe
    K Okamoto
    S Yonehara
    Cell Death & Differentiation, 2005, 12 : 10 - 18
  • [28] Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP
    Watanabe, K
    Okamoto, K
    Yonehara, S
    CELL DEATH AND DIFFERENTIATION, 2005, 12 (01): : 10 - 18
  • [29] The HDAC Inhibitor Vorinostat Diminishes the In Vitro Metastatic Behavior of Osteosarcoma Cells
    Mu, Xiaodong
    Brynien, Daniel
    Weiss, Kurt R.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [30] The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo
    Booth, Laurence
    Roberts, Jane L.
    Sander, Cindy
    Lee, John
    Kirkwood, John M.
    Poklepovic, Andrew
    Dent, Paul
    ONCOTARGET, 2017, 8 (10) : 16367 - 16386
12345